GHRP-6
Growth Hormone Releasing Peptide-6
Regulatory Status
Included in the PeptideUnicorn FDA reclassification tracker as under review.
FDA · Updated May 2026
Generally treated as research-only outside licensed channels.
MHRA · Updated May 2026
Not listed in the public tracker dataset; supply claims require case-by-case review.
TGA · Updated May 2026
Growth-hormone secretagogues are prohibited for athletes subject to anti-doping rules.
WADA · Updated May 2026
Overview
GHRP-6 is a growth hormone releasing peptide associated with ghrelin-receptor and appetite-related research. PeptideUnicorn currently treats this as a stub profile while the full evidence summary and citation set are prepared.
Regulatory Context
GHRP-6 is included in the 2026 FDA peptide reclassification tracker as under review. This page is educational only and should not be interpreted as medical, legal, or sourcing advice.
Continue Reading
Readers also explore
GHRP-2
Growth Hormone Releasing Peptide-2
Growth hormone signaling · Body composition research
Open profileHexarelin
Hexarelin
Growth hormone signaling · Recovery research
Open profileIpamorelin
Ipamorelin Acetate
growth hormone release · muscle growth · fat loss
Open profileState of Peptides 2026
Get the free report and peptide profile updates.
Evidence notes, regulatory changes, and practical research guides in your inbox. Education only - not medical advice.
Get the PeptideUnicorn update
New profiles, regulatory changes, practical guides, and vendor review notes delivered to your inbox.
Get our free State of Peptides 2026 report when you subscribe.